These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2810332)

  • 21. Orally absorbable cephalosporin antibiotics. 1. Structure-activity relationships of benzothienyl- and naphthylglycine derivatives of 7-aminodeacetoxycephalosporanic acid.
    Kukolja S; Draheim SE; Pfeil JL; Cooper RD; Graves BJ; Holmes RE; Neel DA; Huffman GW; Webber JA; Kinnick MD
    J Med Chem; 1985 Dec; 28(12):1886-96. PubMed ID: 2933519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
    Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
    Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
    Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis and antibacterial activity of 7 beta-[2-(2-substituted aminothiazol-4-yl)-(Z)-2-methoxyiminoacetylamido]-3-quaternaryammoniummethyl-cephalosporins].
    Chen GH; Yang Y; Ren Z; Zhong QX
    Yao Xue Xue Bao; 2009 Apr; 44(4):366-70. PubMed ID: 19545053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates].
    Yamaguchi K; Ohno A; Takahashi S; Hayashi M; Yamanaka K; Hirakata Y; Mitsuyama J
    Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antibacterial activities of 2-oxaisocephems.
    Tsubouchi H; Tsuji K; Yasumura K; Ishikawa H
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2084-9. PubMed ID: 7805133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial Activity of New 2-Thioxo-benzo[g]quinazolin-4(3H)-one Derivatives.
    Al-Salahi R; Abuelizz HA; Dib RE; Marzouk M; Alshammari MB
    Med Chem; 2016; 13(1):85-92. PubMed ID: 27306606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on beta-lactam antibiotics. III. Synthesis and enzymatic stability of 3-acyloxymethyl-7 beta-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-cephem-4-carboxylic acids.
    Takaya T; Takasugi H; Murakawa T; Nakano H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1300-10. PubMed ID: 7309624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum.
    Song HK; Oh JI; Kim MY; Kim YZ; Kim IC; Kwak JH
    J Antimicrob Chemother; 1996 Apr; 37(4):711-26. PubMed ID: 8722537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of cefepime in vitro.
    Liu YC; Huang WK; Cheng DL
    Chemotherapy; 1994; 40(6):384-90. PubMed ID: 7842821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
    Pillar CM; Aranza MK; Shah D; Sahm DF
    J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial activity of cefodizime against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Suzuki K
    Jpn J Antibiot; 1993 Oct; 46(10):860-76. PubMed ID: 8254888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients.
    Sultan T; Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(2):80-91. PubMed ID: 8131638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
    Matsuzaki K; Watabe E; Yoshimori K; Shikano M; Sato Y; Hasegawa M; Kobayashi I
    Jpn J Antibiot; 2002 Dec; 55(6):800-7. PubMed ID: 12621734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.
    Ternansky RJ; Draheim SE; Pike AJ; Bell FW; West SJ; Jordan CL; Wu CY; Preston DA; Albron W; Kasher JS
    J Med Chem; 1993 Jul; 36(14):1971-6. PubMed ID: 8336336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):1-21. PubMed ID: 11977919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
    Pulverer G; Peters G; Kunstmann G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
    Balsamo A; Broccali G; Lapucci A; Macchia B; Macchia F; Orlandini E; Rossello A
    J Med Chem; 1989 Jun; 32(6):1398-401. PubMed ID: 2724308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of cationic norbornanes as peptidomimetic antibacterial agents.
    Hickey SM; Ashton TD; Khosa SK; Robson RN; White JM; Li J; Nation RL; Yu HY; Elliott AG; Butler MS; Huang JX; Cooper MA; Pfeffer FM
    Org Biomol Chem; 2015 Jun; 13(22):6225-41. PubMed ID: 25958967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flomoxef showed excellent in vitro activity against clinically important gram-positive and gram-negative pathogens causing community- and hospital-associated infections.
    Yang Q; Zhang H; Cheng J; Xu Z; Hou X; Xu Y
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):269-74. PubMed ID: 25641126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.